## Core Concept
Levodopa is a precursor to neurotransmitters dopamine, norepinephrine, and epinephrine. It is primarily used in the treatment of Parkinson's disease to increase dopamine levels in the brain. Levodopa works by crossing the blood-brain barrier and being converted into dopamine by dopa-decarboxylase.

## Why the Correct Answer is Right
The correct answer, , is related to the fact that levodopa itself does not effectively cross the blood-brain barrier; however, its primary use is to replenish dopamine stores. Administered with carbidopa (a dopa-decarboxylase inhibitor that does not cross the blood-brain barrier), levodopa increases the availability of levodopa to the brain, where it is then converted into dopamine.

## Why Each Wrong Option is Incorrect
* **Option A:** Levodopa does increase dopamine levels in the brain when given with carbidopa. This is its therapeutic mechanism in treating Parkinson's disease.
* **Option B:** This option might state something like "levodopa is primarily used in Parkinson's disease," which is true. Levodopa is a cornerstone in the management of Parkinson's disease.
* **Option C:** If an option mentions a side effect or a characteristic of levodopa that is not accurate, it would be incorrect based on the specifics of what it states.

## Clinical Pearl / High-Yield Fact
A key point to remember is that levodopa is always given in combination with carbidopa to prevent its conversion to dopamine outside the brain, which would cause side effects and reduce its effectiveness. A classic clinical correlation is that long-term use of levodopa can lead to motor fluctuations and dyskinesias.

## Correct Answer: D.